Genetics of experimental allergic encephalomyelitis supports the role of T helper cells in multiple sclerosis pathogenesis

Annals of Neurology

Volumn 70, Issue 6, 2011, Pages 887-896

  Blankenhorn, Elizabeth P ^a   Butterfield, Russell ^b   Case, Laure K ^c   Wall, Emma H ^c   Del Rio, Roxana ^c   Diehl, Sean A ^c   Krementsov, Dimitry N ^c   Saligrama, Naresha ^c   Teuscher, Cory ^c,d,e  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF VERMONT   (United States)

^e University of Houston   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR FOXP3;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOINFORMATICS; CD4+ T LYMPHOCYTE; CHROMOSOME 17; COMPUTER PROGRAM; CONTROLLED STUDY; EFFECTOR CELL; GENE LOCUS; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC RESISTANCE; GENETIC SUSCEPTIBILITY; GENOTYPE; HELPER CELL; IMMUNOPATHOGENESIS; LYMPH NODE; LYMPHOCYTE DIFFERENTIATION; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PREDICTION; PRIORITY JOURNAL; QUANTITATIVE TRAIT LOCUS; REGULATORY T LYMPHOCYTE;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; COMPUTATIONAL BIOLOGY; DISEASE MODELS, ANIMAL; DISEASE SUSCEPTIBILITY; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FLOW CYTOMETRY; FREUND'S ADJUVANT; GENETIC LINKAGE; GENOME-WIDE ASSOCIATION STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX; MICE; MICE, CONGENIC; MULTIPLE SCLEROSIS; PHENOTYPE; QUANTITATIVE TRAIT LOCI; STATISTICS, NONPARAMETRIC; T-LYMPHOCYTES, HELPER-INDUCER;

EID: 84255179025     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.22642     Document Type: Article

References (45)

1. McFarland HF, Martin R,. Multiple sclerosis: a complicated picture of autoimmunity. Nat Immunol 2007; 8: 913-919. (Pubitemid 47300005)
2. Schmidt H, Williamson D, Ashley-Koch A,. HLA-DR15 haplotype and multiple sclerosis: a HuGE review. Am J Epidemiol 2007; 165: 1097-1109. (Pubitemid 47233710)
3. Fazekas G, Tabira T,. What transgenic and knockout mouse models teach us about experimental autoimmune encephalomyelitis. Rev Immunogenet 2000; 2: 115-132. (Pubitemid 30142490)
4. McDonald WI, Compston A, Edan G, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 2001; 50: 121-127.
5. Blankenhorn EP, Butterfield RJ, Rigby R, et al. Genetic analysis of the influence of pertussis toxin on experimental allergic encephalomyelitis susceptibility: an environmental agent can override genetic checkpoints. J Immunol 2000; 164: 3420-3425. (Pubitemid 30149009)
6. Butterfield RJ, Blankenhorn EP, Roper RJ, et al. Genetic analysis of disease subtypes and sexual dimorphisms in mouse experimental allergic encephalomyelitis (EAE): relapsing/remitting and monophasic remitting/ nonrelapsing EAE are immunogenetically distinct. J Immunol 1999; 162: 3096-3102. (Pubitemid 29309341)
7. Butterfield RJ, Blankenhorn EP, Roper RJ, et al. Identification of genetic loci controlling the characteristics and severity of brain and spinal cord lesions in experimental allergic encephalomyelitis. Am J Pathol 2000; 157: 637-645. (Pubitemid 30626922)
8. Butterfield RJ, Sudweeks JD, Blankenhorn EP, et al. New genetic loci that control susceptibility and symptoms of experimental allergic encephalomyelitis in inbred mice. J Immunol 1998; 161: 1860-1867. (Pubitemid 28387607)
9. Encinas JA, Lees MB, Sobel RA, et al. Genetic analysis of susceptibility to experimental autoimmune encephalomyelitis in a cross between SJL/J and B10.S mice. J Immunol 1996; 157: 2186-2192. (Pubitemid 126449699)
10. Encinas JA, Lees MB, Sobel RA, et al. Identification of genetic loci associated with paralysis, inflammation and weight loss in mouse experimental autoimmune encephalomyelitis. Int Immunol 2001; 13: 257-264. (Pubitemid 32179073)
11. Teuscher C, Bunn JY, Fillmore PD, et al. Gender, age, and season at immunization uniquely influence the genetic control of susceptibility to histopathological lesions and clinical signs of experimental allergic encephalomyelitis: implications for the genetics of multiple sclerosis. Am J Pathol 2004; 165: 1593-1602. (Pubitemid 39435158)
12. Teuscher C, Butterfield RJ, Ma RZ, et al. Sequence polymorphisms in the chemokines Scya1 (TCA-3), Scya2 (monocyte chemoattractant protein (MCP)-1), and Scya12 (MCP-5) are candidates for eae7, a locus controlling susceptibility to monophasic remitting/nonrelapsing experimental allergic encephalomyelitis. J Immunol 1999; 163: 2262-2266. (Pubitemid 29382236)
13. Abiola O, Angel JM, Avner P, et al. The nature and identification of quantitative trait loci: a community's view. Nat Rev Genet 2003; 4: 911-916.
14. Teuscher C, Doerge RW, Fillmore PD, et al. eae36, a locus on mouse chromosome 4, controls susceptibility to experimental allergic encephalomyelitis in older mice and mice immunized in the winter. Genetics 2006; 172: 1147-1153. (Pubitemid 43345446)
15. Dai YD, Marrero IG, Gros P, et al. Slc11a1 enhances the autoimmune diabetogenic T-cell response by altering processing and presentation of pancreatic islet antigens. Diabetes 2009; 58: 156-164.
16. Fillmore PD, Blankenhorn EP, Zachary JF, et al. Adult gonadal hormones selectively regulate sexually dimorphic quantitative traits observed in experimental allergic encephalomyelitis. Am J Pathol 2004; 164: 167-175. (Pubitemid 38364601)
17. Fillmore PD, Brace M, Troutman SA, et al. Genetic analysis of the influence of neuroantigen-complete Freund's adjuvant emulsion structures on the sexual dimorphism and susceptibility to experimental allergic encephalomyelitis. Am J Pathol 2003; 163: 1623-1632. (Pubitemid 37175109)
18. Benjamini Y, Drai D, Elmer G, et al. Controlling the false discovery rate in behavior genetics research. Behav Brain Res 2001; 125: 279-284. (Pubitemid 33000466)
19. Falk K, Rotzschke O, Santambrogio L, et al. Induction and suppression of an autoimmune disease by oligomerized T cell epitopes: enhanced in vivo potency of encephalitogenic peptides. J Exp Med 2000; 191: 717-730.
20. Matesanz F, Caro-Maldonado A, Fedetz M, et al. IL2RA/CD25 polymorphisms contribute to multiple sclerosis susceptibility. J Neurol 2007; 254: 682-684. (Pubitemid 46781978)
21. Vinuesa CG, Cook MC, Angelucci C, et al. A RING-type ubiquitin ligase family member required to repress follicular helper T cells and autoimmunity. Nature 2005; 435: 452-458. (Pubitemid 40734237)
22. Williams LM, Rudensky AY,. Maintenance of the Foxp3-dependent developmental program in mature regulatory T cells requires continued expression of Foxp3. Nat Immunol 2007; 8: 277-284. (Pubitemid 46745377)
23. del Rio R, Sun Y, Alard P, et al. H2 control of natural T regulatory cell frequency in the lymph node correlates with susceptibility to day 3 thymectomy-induced autoimmune disease. J Immunol 2011; 186: 382-389.
24. Wicker LS, Todd JA, Peterson LB,. Genetic control of autoimmune diabetes in the NOD mouse. Annu Rev Immunol 1995; 13: 179-200.
25. Jagodic M, Colacios C, Nohra R, et al. A role for VAV1 in experimental autoimmune encephalomyelitis and multiple sclerosis. Sci Transl Med 2009; 1: 10ra21.
26. Korn T, Fischer KD, Girkontaite I, et al. Vav1-deficient mice are resistant to MOG-induced experimental autoimmune encephalomyelitis due to impaired antigen priming. J Neuroimmunol 2003; 139: 17-26. (Pubitemid 36694386)
27. Colacios C, Casemayou A, Dejean AS, et al. The p.Arg63Trp polymorphism controls Vav1 functions and Foxp3 regulatory T cell development. J Exp Med 2011; 24: 2183-2191.
28. International Multiple Sclerosis Genetics Consortium; Wellcome Trust Case Control Consortium 2, Sawcer S, Hellenthal G, Pirinen M, et al. Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature 2011; 476: 214-219.
29. Wang Y, Zhu M, Miller M, et al. Immunoregulation by tumor necrosis factor superfamily member LIGHT. Immunol Rev 2009; 229: 232-243.
30. Matesanz F, Fedetz M, Collado-Romero M, et al. Allelic expression and interleukin-2 polymorphisms in multiple sclerosis. J Neuroimmunol 2001; 119: 101-105. (Pubitemid 32781734)
31. Hafler DA, Compston A, Sawcer S, et al. Risk alleles for multiple sclerosis identified by a genomewide study. N Engl J Med 2007; 357: 851-862. (Pubitemid 47347319)
32. del Rio R, Noubade R, Subramanian M, et al. SNPs upstream of the minimal promoter control IL-2 expression and are candidates for the autoimmune disease-susceptibility locus Aod2/Idd3/Eae3. Genes Immun 2008; 9: 115-121.
33. Matejuk A, Bakke AC, Hopke C, et al. Estrogen treatment induces a novel population of regulatory cells, which suppresses experimental autoimmune encephalomyelitis. J Neurosci Res 2004; 77: 119-126. (Pubitemid 38850062)
34. Polanczyk MJ, Carson BD, Subramanian S, et al. Cutting edge: estrogen drives expansion of the CD4+CD25+ regulatory T cell compartment. J Immunol 2004; 173: 2227-2230. (Pubitemid 39063075)
35. Munger KL, Levin LI, Hollis BW, et al. Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA 2006; 296: 2832-2838. (Pubitemid 44969183)
36. Wingerchuk DM, Lesaux J, Rice GP, et al. A pilot study of oral calcitriol (1,25-dihydroxyvitamin D3) for relapsing-remitting multiple sclerosis. J Neurol Neurosurg Psychiatry 2005; 76: 1294-1296. (Pubitemid 41208389)
37. Spach KM, Hayes CE,. Vitamin D3 confers protection from autoimmune encephalomyelitis only in female mice. J Immunol 2005; 175: 4119-4126. (Pubitemid 41292076)
38. Joshi S, Pantalena LC, Liu XK, et al. 1,25-Dihydroxyvitamin D3 ameliorates Th17 autoimmunity via transcriptional modulation of interleukin-17A. Mol Cell Biol 2011; 31: 3653-3669.
39. Mayne CG, Spanier JA, Relland LM, et al. 1,25-Dihydroxyvitamin D3 acts directly on the T lymphocyte vitamin D receptor to inhibit experimental autoimmune encephalomyelitis. Eur J Immunol 2011; 41: 822-832.
40. Pritchard JK,. Are rare variants responsible for susceptibility to complex diseases? Am J Hum Genet 2001; 69: 124-137. (Pubitemid 32614025)
41. Jakkula E, Leppa V, Sulonen AM, et al. Genome-wide association study in a high-risk isolate for multiple sclerosis reveals associated variants in STAT3 gene. Am J Hum Genet 2010; 86: 285-291.
42. Spach KM, Noubade R, McElvany B, et al. A single nucleotide polymorphism in Tyk2 controls susceptibility to experimental allergic encephalomyelitis. J Immunol 2009; 182: 7776-7783.
43. Teuscher C,. Experimental allergic orchitis in mice. II. Association of disease susceptibility with the locus controlling Bordetella pertussis-induced sensitivity to histamine. Immunogenetics 1985; 22: 417-425. (Pubitemid 16243938)
44. Teuscher C, Blankenhorn EP, Hickey WF,. Differential susceptibility to actively induced experimental allergic encephalomyelitis and experimental allergic orchitis among BALB/c substrains. Cell Immunol 1987; 110: 294-304. (Pubitemid 18031636)
45. Bunce M, O''Neil CM, Barnardo MC, et al. Phototyping: comprehensive DNA typing for HLA-A, B, C, DRB1, DRB3, DRB4, DRB5, and DQB1 by PCR with 144 primer mixes utilizing sequence-specific primers (PCR-SSP). Tissue Antigens 1995; 46: 355-367. (Pubitemid 26001354)